jeffrey berger, md: deciding between glp1 agonists or sglt2 inhibitors
Published 5 years ago • 2.6K plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
7:43
choosing sglt2 inhibitors vs glp-1 receptor agonists
-
2:13
peter toth, md: glp-1 agonists and sglt-2 inhibitors for diabetes
-
1:30
jeffrey berger, md: importance of real-world data
-
1:47
robert gabbay, md, phd: the debate about sglt-2 inhibitors and glp-1 receptor agonists
-
6:11
benefits of sglt2 inhibitors and glp-1 receptor agonists
-
2:27
jeffrey berger, md: implications of new aspirin data in 2019
-
15:34
sglt2 inhibitors vs glp-1 agonists: a cardiologist and an endocrinologist weigh in
-
2:12
jeffrey berger, md: impact of tavr on antithrombotic strategy
-
3:07
using glp-1 agonists & sglt-2 inhibitors together from the cardiologist's perspective (sglt2 & glp1)
-
1:35
jeffrey berger, md: future role of aspirin in cardiology
-
3:32
understanding how sglt2 inhibitors and glp-1 agonists work - medpage today
-
26:43
prof melanie davies - 'do glp-1 analogues and sglt2 inhibitors have a role beyond type 2 diabetes?'
-
7:11
glp-1 agonists: cv outcomes data in type 2 diabetes
-
2:09
dr darren k. mcguire discusses use of sglt2 inhibitors and glp-1 receptor agonists in t2d
-
53:29
efl033 - glp-1 receptor agonists and sglt2 inhibitors in type 1 diabetes
-
2:33
dr darren mcguire debates sglt2 inhibitors and glp-1 receptor agonists as cvd prime time prevention
-
1:43
glp 1 receptor agonist/insulin combinations
-
6:15
glp-1 agonist therapy in a patient with t2d and cvd